Distributions and chemical forms of arsenic after intravenous administration of dimethylarsinic and monomethylarsonic acids to rats

Toxicology and Applied Pharmacology

Volumn 198, Issue 3, 2004, Pages 336-344

  Suzuki, Kazuo T ^a   Katagiri, Akio ^a   Sakuma, Yoko ^a   Ogra, Yasumitsu ^a   Ohmichi, Masayoshi ^b  

^a CHIBA UNIVERSITY   (Japan)

^b Chiba City Institute of Health and Environment   (Japan)

Author keywords

arsenate; Arsenic; arsenite; arsenobetaine; arsenocholine; AsB; AsC; dimethylarsinic acid; dimethylarsinous acid; dimethylated arsenic; DMA; DMAIII; DMAV; iAsIII; iAsV; MMA; MMAIII; monomethylated arsenic

Indexed keywords

ARSENIC; ARSENIC TRIOXIDE; CACODYLIC ACID; METHANEARSONIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE FLOW; BLOOD FLOW; BODY FLUID; CONTROLLED STUDY; ERYTHROCYTE; INJECTION; LIVER; MALE; METABOLISM; METABOLITE; METHYLATION; NONHUMAN; ORGAN; RAT; TISSUE LEVEL; URINARY EXCRETION;

ANIMALS; ARSENICALS; CACODYLIC ACID; HERBICIDES; INJECTIONS, INTRAVENOUS; LIVER; MALE; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

ANIMALIA; MAMMALIA;

EID: 3242682110     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2003.10.029     Document Type: Article

References (43)

1. Aposhian H.V. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu. Rev. Pharmacol. Toxicol. 37:1997;397-419
2. Aposhian H.V., Gurzau E.S., Le X.C., Gurzau A., Healy S.M., Lu X., Ma M., Yip L., Zakharyan R.A., Maiorino R.M., Dart R.C., Tircus M.G., Gonzalez Ramirez D., Morgan D.L., Avram D., Aposhian M.M. Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem. Res. Toxicol. 13:2000;693-697
3. Buchet J.P., Lauwerys R., Roels H. Comparison of the urinary excretion of arsenic metabolites after a single dose of sodium arsenite, monomethylarsonate or dimethylarsinate in man. Int. Arch. Occup. Environ. Health. 48:1981;71-79
4. Csanaky I., Gregus Z. Species variations in the biliary and urinary excretion of arsenate, arsenite and their metabolites. Comp. Biochem. Physiol., Part C: Pharmacol., Toxicol. Endocrinol. 131:2002;355-365
5. Cullen W., Mcbride B.C., Reglinski J. The reaction of methylarsenicals with thiols: some biological implications. J. Inorg. Biochem. 21:1984;179-194
6. Del Razo L.M., Styblo M., Cullen W.R., Thomas D.J. Determination of trivalent methylated arsenicals in biological matrices. Toxicol. Appl. Pharmacol. 174:2001;282-293
7. Fischer A.B., Buchet J.P., Lauwerys R.R. Arsenic uptake, cytotoxicity and detoxification studied in mammalian cells in culture. Arch. Toxicol. 57:1985;168-172
8. Francesconi K.A., Tanggaar R., McKenzie C.J., Goessler W. Arsenic metabolites in human urine after ingestion of an arsenosugar. Clin. Chem. 48:2002;92-101
9. Goering P.L., Aposhian H.V., Mass M.J., Cebrian M., Beck B.D., Waalkes M.P. The enigma of arsenic carcinogenesis: role of metabolism. Toxicol. Sci. 49:1999;5-14
10. Gregus Z., Gyurasics A., Csanaky I. Biliary and urinary excretion of inorganic arsenic: monomethylarsonous acid as a major biliary metabolite in rats. Toxicol. Sci. 56:2000;18-25
11. Hughes M.F., Kenyon E.M. Dose-dependent effects on the disposition of monomethylarsonic acid and dimethylarsinic acid in the mouse after intravenous administration. J. Toxicol. Environ. Health, Part A. 53:1998;95-112
12. Hughes M.F., Menache M., Thompson D.J. Dose-dependent disposition of sodium arsenate in mice following acute oral exposure. Fundam. Appl. Toxicol. 22:1994;80-89
13. Hughes M.F., Kenyon E.M., Edwards B.C., Mitchell C.T., Thomas D.J. Strain-dependent disposition of inorganic arsenic in the mouse. Toxicology. 137:1999;95-108
14. IPCS Arsenic. 1981;World Health Organization
15. IPCS Arsenic and Arsenic Compounds. 2001;World Health Organization, Geneva
16. Kala S.V., Neely M.W., Kala G., Prater C.I., Atwood D.W., Rice J.S., Lieberman M.W. The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. J. Biol. Chem. 275:2000;33404-33408
17. Kitchin K.Y. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Phamacol. 172:2001;249-261
18. Kool M., de Haas M., Scheffer G.L., Scheper R.J., Van Eijk M.J.T., Juijn J.A., Baas F., Borst P. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 57:1997;3537-3547
19. Le X.C., Lu X., Ma M., Cullen W.R., Aposhian H.V., Zheng B. Speciation of key arsenic metabolic intermediates in human urine. Anal. Chem. 72:2000;5172-5177
20. Le C.X., Ma M., Lu X., Cullen W.R., Aposhian H.V., Zheng B. Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ. Health Perspect. 108:2000;1015-1018
21. Lerman S., Clarkson T.W. The metabolism of arsenite and arsenate by the rat. Fundam. Appl. Toxicol. 3:1983;309-314
22. Leslie E.M., Deeley R.G., Cole S.P.C. Toxicological relevance of the multidrug resistance protein 1. MRP1(ABCC1) and related transporters. Toxicology. 167:2001;3-23
23. Mandal B.K., Ogra Y., Suzuki K.T. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem. Res. Toxicol. 14:2001;371-378
24. Marafante E., Vahter M., Norm H., Envall J., Sandstrom M., Christakopoulos A., Ryhage R. Biotransformation of dimethylarsinic acid in mouse, hamster and man. J. Appl. Toxicol. 7:1987;111-117
25. National Research Council Medical and biological effects of environmental pollutants. Arsenic. 1977;229 National Academy of Sciences, Washington, DC
26. Nemeti B., Gregus Z. Reduction of arsenate to arsenite in hepatic cytosol. Toxicol. Sci. 70:2002;4-12
27. Radabaugh T.R., Aposhian H.V. Enzymatic reduction of arsenic compounds in mammalian systems: reduction of arsenate to arsenite by human liver arsenate reductase. Chem. Res. Toxicol. 13:2000;26-30
28. III) by red blood cells. Chem. Res. Toxicol. 14:2001;1446-1452
29. Styblo M., Del Razo L.M., LeCluyse E.L., Hamilton G.A., Wang C., Cullen W.R., Thomas D.J. Metabolism of arsenic in primary cultures of human and rat hepatocytes. Chem. Res. Toxicol. 12:1999;560-565
30. Styblo M., Del Razo L.M., Vega L., Germolec D.R., LeCluyse E.L., Hamilton G.A., Reed W., Wang C., Cullen W.R., Thomas D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74:2000;289-299
31. Suzuki K.T., Tomita T., Ogra Y., Ohmichi M. Glutathione-conjugated arsenics in the potential hepato-enteric circulation in rats. Chem. Res. Toxicol. 14:2001;1604-1611
32. Suzuki K.T., Mandal B.K., Ogra Y. Speciation of arsenic in body fluids. Talanta. 58:2002;111-119
33. Suzuki K.T., Tomita T., Ogra Y., Ohmichi M. Arsenic metabolism in hyperbilirubinemic rats: distribution and excretion in relation to transformation. Chappell W.R., Abernathy C.O., Calderon R.L. Arsenic Exposure and Health Effects. vol. V:2003;Elsevier, London. In press
34. 74As) in humans following oral ingestion. Toxicol. Appl. Pharmacol. 50:1979;319-322
35. Vahter M. Species differences in the metabolism of arsenic compounds. Appl. Organomet. Chem. 8:1994;175-182
36. Vahter M. Methylation of inorganic arsenic in different mammalian species and population groups. Sci. Prog. 82:1999;69-88
37. Vahter M., Marafante E. Intracellular interaction and metabolic fate of arsenite and arsenate in mice and rabbits. Chem.-Biol. Interact. 47:1983;29-44
38. 74As-dimethylarsinic acid in mice and rats. Arch. Environ. Contam. Toxicol. 13:1984;259-264
39. Yamauchi H., Yamamura Y. Metabolism and excretion of orally administered dimethylarsinic acid in the hamster. Toxicol. Appl. Pharmacol. 74:1984;134-140
40. Yamauchi H., Yamamura Y. Metabolism and excretion of orally administrated arsenic trioxide in the hamster. Toxicology. 34:1985;113-121
41. Yamauchi H., Kaise T., Takahashi K., Yamamura Y. Toxicity and metabolism of trimethylarsine in mice and hamsters. Fundam. Appl. Toxicol. 14:1990;399-407
42. Yoshida K., Hua C.K., Inoue Y., Wanibuchi H., Fukushima S., Kuroda K., Endo G. The urinary excretion of arsenic metabolites after a single oral administration of dimethylarsinic acid to rats. Arch. Environ. Contam. Toxicol. 32:1997;416-421
43. Yoshida K., Inoue Y., Hua C.K., Fukushima S., Wanibuchi H., Endo G. Urinary excretion of arsenic metabolites after long-term oral administration of various arsenic compounds to rats. J. Toxicol. Environ. Health, Part A. 54:1998;179-192